Cwm, LLC Nkarta, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Cwm, LLC holds 28,512 shares of NKTX stock, worth $69,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,512

Previous 34,758 17.97%

Holding current value

$69,569

Previous $58,000 1.72%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$1.67 - $2.37 $10,430 - $14,803	-6,246 Reduced 17.97%	28,512 $59,000
Q2 2025 Jul 25, 2025	BUY	$1.51 - $2.22 $9,967 - $14,654	6,601 Added 23.44%	34,758 $58,000
Q1 2025 May 01, 2025	BUY	$1.37 - $2.53 $37,484 - $69,223	27,361 Added 3437.31%	28,157 $52,000
Q4 2024 Feb 04, 2025	SELL	$2.17 - $4.34 $8,393 - $16,787	-3,868 Reduced 82.93%	796 $2,000
Q3 2024 Oct 08, 2024	BUY	$4.52 - $8.0 $194 - $344	43 Added 0.93%	4,664 $21,000
Q2 2024 Jul 09, 2024	BUY	$5.27 - $10.82 $6,735 - $13,827	1,278 Added 38.23%	4,621 $27,000
Q1 2024 Apr 05, 2024	BUY	$5.59 - $15.71 $5,405 - $15,191	967 Added 40.7%	3,343 $36,000
Q4 2023 Feb 01, 2024	SELL	$1.31 - $6.6 $1,471 - $7,411	-1,123 Reduced 32.09%	2,376 $16,000
Q3 2023 Oct 11, 2023	SELL	$1.39 - $2.29 $261 - $430	-188 Reduced 5.1%	3,499 $5,000
Q2 2023 Aug 03, 2023	SELL	$2.19 - $5.17 $1,110 - $2,621	-507 Reduced 12.09%	3,687 $8,000
Q1 2023 Apr 28, 2023	SELL	$3.37 - $6.3 $236,729 - $442,549	-70,246 Reduced 94.37%	4,194 $15,000
Q4 2022 Feb 01, 2023	SELL	$5.14 - $14.35 $73,728 - $205,836	-14,344 Reduced 16.16%	74,440 $446,000
Q3 2022 Oct 27, 2022	SELL	$12.27 - $18.39 $26,319 - $39,446	-2,145 Reduced 2.36%	88,784 $1.17 Million
Q2 2022 Jul 28, 2022	SELL	$7.77 - $19.44 $89,355 - $223,560	-11,500 Reduced 11.23%	90,929 $1.12 Million
Q1 2022 Apr 21, 2022	SELL	$8.66 - $14.99 $88,981 - $154,022	-10,275 Reduced 9.12%	102,429 $1.17 Million
Q4 2021 Jan 31, 2022	SELL	$12.79 - $26.88 $151,126 - $317,614	-11,816 Reduced 9.49%	112,704 $1.73 Million
Q1 2021 Sep 15, 2021	BUY	$31.33 - $59.61 $2.24 Million - $4.26 Million	71,535 Added 135.01%	124,520 $3.95 Million
Q1 2021 Apr 27, 2021	SELL	$31.33 - $59.61 $2.24 Million - $4.26 Million	-71,535 Reduced 57.45%	52,985 $1.74 Million
Q4 2020 Sep 15, 2021	BUY	$27.03 - $75.62 $1.98 Million - $5.53 Million	73,099 Added 142.16%	124,520 $3.95 Million
Q4 2020 Jan 27, 2021	SELL	$27.03 - $75.62 $1.98 Million - $5.53 Million	-73,099 Reduced 58.7%	51,421 $3.16 Million
Q3 2020 Sep 15, 2021	BUY	$23.52 - $47.9 $2.93 Million - $5.96 Million	124,520 New	124,520 $3.95 Million
Q3 2020 Oct 19, 2020	SELL	$23.52 - $47.9 $2.93 Million - $5.96 Million	-124,520 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	N/A	124,520 New	124,520 $3.95 Million
Q2 2020 Jul 22, 2020	SELL	N/A	-124,520 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	N/A	124,520 New	124,520 $3.95 Million
Q1 2020 Apr 28, 2020	SELL	N/A	-124,520 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	N/A	124,520 New	124,520 $3.95 Million
Q4 2019 Jan 27, 2020	SELL	N/A	-124,520 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	N/A	124,520 New	124,520 $3.95 Million
Q3 2019 Oct 22, 2019	SELL	N/A	-124,520 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	N/A	124,520 New	124,520 $3.95 Million
Q2 2019 Jul 31, 2019	SELL	N/A	-124,520 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	N/A	124,520 New	124,520 $0

Others Institutions Holding NKTX

# of Institutions

113

Shares Held

59.1M

Call Options Held

Put Options Held

67.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account